Reporting variability can lead to inconsistencies in the diagnosis, treatment, and management of cancer. For instance, variability in reporting tumor size, grade, and stage can affect treatment plans. Inconsistent reporting can also hinder the comparability of clinical trial results, making it difficult to assess the efficacy of new treatments or interventions.
